Avon Lifesciences - Kobo Biotech Share Price

	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023
Total Income	0.02	0.00	0.00	0.00	0.02
Total Income Growth (%)	-	-	-	-100.00	-
Total Expenses	1.35	1.26	1.23	1.22	1.24
Total Expenses Growth (%)	7.75	2.03	1.28	-2.04	-30.80
EBIT	-1.33	-1.26	-1.23	-1.22	-1.23
EBIT Growth (%)	-	-	-	-	-
Profit after Tax (PAT)	-1.33	-1.26	-1.23	-1.22	-1.23
PAT Growth (%)	-	-	-	-	-
EBIT Margin (%)	0.00	-	-	-	0.00
Net Profit Margin (%)	0.00	-	-	-	0.00
Basic EPS (₹)	-0.56	-0.53	-0.52	-0.51	-0.51

Annual	FY 2014	FY 2013	FY 2012
Total Revenue	103.44	404.02	287.50
Total Revenue Growth (%)	-74.40	40.53	77.06
Total Expenses	137.71	389.15	269.83
Total Expenses Growth (%)	-64.61	44.22	76.90
Profit after Tax (PAT)	-34.82	13.99	15.12
PAT Growth (%)	-348.82	-7.43	53.58
Operating Profit Margin (%)	-9.97	8.24	13.31
Net Profit Margin (%)	-33.73	3.46	5.26
Basic EPS (₹)	-15.47	6.22	4.47

	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	0.02	0.02	0.02	0.04	0.03
Total Revenue Growth (%)	0.00	-8.43	-53.70	4.15	1.58
Total Expenses	4.94	5.57	15.24	19.27	22.96
Total Expenses Growth (%)	-11.22	-63.47	-20.89	-16.09	2.92
Profit after Tax (PAT)	-4.93	-5.55	-15.23	-19.23	-21.01
PAT Growth (%)	-	-	-	-	-
Operating Profit Margin (%)	0.00	0.00	0.00	0.00	0.00
Net Profit Margin (%)	0.00	0.00	0.00	0.00	0.00
Basic EPS (₹)	-2.33	-2.33	-6.39	-8.07	-8.82

All figures in Rs Cr, unless mentioned otherwise

View Details

Balance Sheet

Annual	FY 2014	FY 2013	FY 2012
Total Assets	395.58	411.68	345.61
Total Assets Growth (%)	-3.91	19.12	38.25
Total Liabilities	342.50	323.78	269.95
Total Liabilities Growth (%)	5.78	19.94	43.14
Total Equity	53.08	87.89	75.66
Total Equity Growth (%)	-39.61	16.18	23.22
Current Ratio (x)	1.10	1.17	1.26
Total Debt to Equity (x)	3.23	1.78	1.34
Contingent Liabilities	0.64	1.72	3.07

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Assets	71.39	75.33	79.19	230.59	236.33
Total Assets Growth (%)	-5.23	-4.87	-65.66	-2.43	-1.30
Total Liabilities	204.30	203.31	201.61	337.79	324.31
Total Liabilities Growth (%)	0.49	0.84	-40.31	4.16	5.84
Total Equity	-132.91	-127.98	-122.43	-107.20	-87.97
Total Equity Growth (%)	-	-	-	-	-
Current Ratio (x)	0.23	0.23	0.23	0.53	0.56
Total Debt to Equity (x)	-1.05	-1.09	-1.15	-1.94	-2.26
Contingent Liabilities	0.00	-	-	-	-

All figures in Rs Cr, unless mentioned otherwise

View Details

Cash Flows

Annual	FY 2014	FY 2013	FY 2012
Net Cash flow from Operating Activities	6.72	36.72	63.89
Net Cash used in Investing Activities	-4.71	-6.99	-14.43
Net Cash flow from Financing Activities	-12.85	-38.39	-26.82
Net Cash Flow	-10.84	-8.66	22.64
Closing Cash & Cash Equivalent	5.64	16.48	25.13
Closing Cash & Cash Equivalent Growth (%)	-65.77	-34.44	-
Total Debt/ CFO (x)	25.51	4.26	1.55

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash flow from Operating Activities	0.20	0.87	93.76	13.67	14.48
Net Cash used in Investing Activities	-	-	25.09	-	0.00
Net Cash flow from Financing Activities	-0.15	-0.87	-120.28	-12.24	-14.47
Net Cash Flow	0.05	6,000.00	-1.43	1.43	0.00
Closing Cash & Cash Equivalent	0.14	0.13	0.13	1.56	0.13
Closing Cash & Cash Equivalent Growth (%)	8.51	0.40	-91.90	1,120.30	-1.35
Total Debt/ CFO (x)	686.11	159.89	1.50	15.23	13.74

All figures in Rs Cr, unless mentioned otherwise

View Details

Ratios

Annual	FY 2014	FY 2013	FY 2012
Return on Equity (%)	-65.59	15.92	20.45
Return on Capital Employed (%)	-7.79	21.44	23.75
Return on Assets (%)	-8.80	3.39	4.37
Interest Coverage Ratio (x)	-0.43	1.81	1.86
Asset Turnover Ratio (x)	26.08	98.05	83.11
Price to Earnings (x)	-0.57	2.28	4.58
Price to Book (x)	0.37	0.36	0.94
EV/EBITDA (x)	-275.00	3.98	2.95
EBITDA Margin (%)	-0.65	10.71	17.09

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Return on Equity (%)	0.00	0.00	0.00	0.00	0.00
Return on Capital Employed (%)	5.11	6.13	17.93	12.23	17.62
Return on Assets (%)	-6.90	-7.37	-19.22	-8.34	-8.88
Interest Coverage Ratio (x)	0.00	-7,406.50	-77.78	-0.77	-0.58
Asset Turnover Ratio (x)	-	-	-	0.00	0.00
Price to Earnings (x)	-1.84	-0.82	-0.86	-0.92	-0.33
Price to Book (x)	-0.07	-0.04	-0.11	-0.16	-0.08
EV/EBITDA (x)	-173.27	-97.37	-14.66	-81.47	-79.91
EBITDA Margin (%)	0.00	0.00	0.00	0.00	0.00

Found Financials useful?

5 Days	14 Days	28 Days
-	-	-

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Avon Lifesciences	-3.06	0.29	-65.59	-7.79	-8.80	-24.66	-9.97	-33.73	-15.47	1.10	3.23	25.51
Colinz Labs	26.95	1.38	5.12	7.32	4.02	-3.29	11.98	8.38	2.04	3.68	0.04	0.15
Ortin Labs	-18.67	11.18	-59.84	-32.16	-15.93	-58.73	-717.61	-736.71	-0.91	1.60	0.81	-1.80
Beryl Drugs	28.06	1.21	0.00	0.00	0.00	-10.64	8.50	6.21	1.96	0.00	0.00	0.66
Unjha Form	12.53	2.30	18.33	18.65	12.78	6.04	6.10	4.47	1.57	11.83	0.00	0.00
Add More

Annual Ratios (%)

Choose from Peers

Kamron Labs.
Vivanza Biosciences
Brawn Biotech
Shyama Infosys
Advik Labs

Choose from Stocks

Stock Performance

CHART
TABLE

1D
1W
1M
3M
6M
1Y
5Y

Choose from Peers
Choose from Stocks

NAME	1D	1W	1M	3M	1Y	3Y	5Y
Avon Lifesciences Stock Performance	1.89	0.00	116.05	123.53	138.38	152.34	7.67
Colinz Labs Stock Performance	0.67	20.99	14.21	10.10	1.66	51.86	296.61
Ortin Labs Stock Performance	-2.01	0.00	13.33	-10.85	47.83	-13.00	-41.88
Beryl Drugs Stock Performance	2.08	13.53	-4.86	8.49	17.56	67.86	119.42
Unjha Form Stock Performance	0.00	-1.01	-5.97	-12.44	-12.95	45.39	107.37
Add More

Category	No. of Shares	Percentage
Promoters	1,07,09,100	44.95 %
Pledge	0	0.00 %
Others	1,31,15,900	55.05 %

Category	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Promoters	44.95	44.95	44.95	44.95
Pledge	0.00	0.00	0.00	0.00
FII	0.00	0.00	0.00	0.00
DII	0.00	0.00	0.00	0.00
Mutual Funds	0.00	0.00	0.00	0.00
Others	55.05	55.05	55.05	55.05

Mutual Funds Ownership

No Data Available

Corporate Actions

Recent
Board Meeting
Quarterly Results
Aug 12, 2024
Board Meeting
Audited Results
May 23, 2024
Board Meeting
Quarterly Results
Feb 07, 2024

Board Meetings

Announced on	Meeting on
Aug 12, 2024	Aug 14, 2024
Quarterly Results
May 23, 2024	May 30, 2024
Audited Results
Feb 07, 2024	Feb 14, 2024
Quarterly Results
Nov 03, 2023	Nov 10, 2023
Quarterly Results
Aug 03, 2023	Aug 11, 2023
Quarterly Results

Dividends
Announced on Ex-Date Dividend%
May 30, 2012 Sep 21, 2012 10%
May 19, 2011 Jul 22, 2011 10%
Aug 13, 2010 Sep 23, 2010 10%
Oct 01, 2002 Sep 18, 2002 5%
Jul 01, 2002 Sep 18, 2002 5%
Bonus
No Data Available
Splits
No Data Available
Rights
Announced on Ex-Date
Jan 03, 2005 -
Rights ratio: 1 share for every 2 held at a price of Rs 70.0
AGM/EGM Meetings
Announced on Meeting on
May 30, 2023 Sep 30, 2023
-
Feb 27, 2023 Mar 31, 2023
-
May 30, 2022 Sep 30, 2022
-
Jun 30, 2021 Nov 30, 2021
-
Nov 13, 2020 Dec 30, 2020
-

Announced on	Ex-Date	Dividend%
May 30, 2012	Sep 21, 2012	10%
May 19, 2011	Jul 22, 2011	10%
Aug 13, 2010	Sep 23, 2010	10%
Oct 01, 2002	Sep 18, 2002	5%
Jul 01, 2002	Sep 18, 2002	5%

Announced on	Ex-Date
Jan 03, 2005	-
Rights ratio: 1 share for every 2 held at a price of Rs 70.0

Announced on	Meeting on
May 30, 2023	Sep 30, 2023
-
Feb 27, 2023	Mar 31, 2023
-
May 30, 2022	Sep 30, 2022
-
Jun 30, 2021	Nov 30, 2021
-
Nov 13, 2020	Dec 30, 2020
-

About Avon Lifesciences

Kobo Biotech Ltd., incorporated in the year 1993, is a Small Cap company (having a market cap of Rs 15.39 Crore) operating in Pharmaceuticals sector.

Kobo Biotech Ltd. key Products/Revenue Segments include for the year ending 31-Mar-2022.

For the quarter ended 30-06-2024, the company has reported a Standalone Total Income of Rs .02 Crore, unchanged .00 % from last quarter Total Income of Rs .00 Crore and up 58.55 % from last year same quarter Total Income of Rs .02 Crore. Company has reported net profit after tax of Rs -1.33 Crore in latest quarter.

The company’s top management includes Mr.Ajit Kamath, Mr.Rajendra Kaimal, Mr.Abhishek Buddhadev, Dr.Sunil Pitroda, Ms.Urja Shah, Mr.Neelam Kumar Murdia, Mr.Jignesh Patel. Company has N G Jain & Co. as its auditors. As on 31-03-2026, the company has a total of 2.38 Crore shares outstanding.

Avon Lifesciences Share Price Today is Rs. 6.46. On previous day, the Avon Lifesciences Share Price (NSE) closed at Rs. 6.04, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 44.95% of the stake in Avon Lifesciences shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of Avon Lifesciences stocks was 0.0% as compared to 0.0% in Dec 2025 with null of 0.0%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 0.0% as compared to 0.0% in Dec 2025 with null of 0.0%. Out of the total DII holdings in Avon Lifesciences shares 0.0% was held by mutual funds. The rest including public held is 0.0%. Avon Lifesciences stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Avon Lifesciences Dividend: Ever since 1993, Avon Lifesciences dividends has been paid out around 6 times. As on 15 Jun, 2026, 03:50 PM IST, The overall dividend yield for Avon Lifesciences stands at 0.0%. The last dividend paid was on September 21, 2012 (Rs. 1.0). The Earnings Per Share (EPS) for quarter ending 30th Jun 2024 is Rs. -2.11.

Avon Lifesciences Bonus: The most recent bonus issue had been in year null around 0 years ago at 0 : 0 ratio. The first bonus issue was announced in null.

Stock Forecast:
After showing 0.02 Cr. of sales and 100.0% of quarterly net loss, there have been multiple ups and downs in the Avon Lifesciences stock prices in the past few weeks. For example, Avon Lifesciences stock price on 5th of June 2026 was around Rs. 4.99. Avon Lifesciences share price now stands at an average of Rs. 6.46. Judging by last week's performance, stock is in up trend.

Avon Lifesciences has a median target price of Rs. 0.0 in 12 months by 0 analysts. They have provided a high estimate of Rs. 0.0 and low estimate of Rs. 0.0 for Avon Lifesciences share.

Historical Prices and Performance:
Avon Lifesciences,incorporated in 1993 is a Small Cap company (with a market cap of Rs. 15.11) operating in Pharmaceuticals sector.
The Return of Equity (ROE) in last five financial years given by Avon Lifesciences stock was 0.0%, 0.0%, 0.0%, 0.0% and 0.0% respectively.
The Avon Lifesciences share gave a 3 year return of 140.15% as compared to Nifty 50 which gave a return of 26.99%.
Avon Lifesciences announced 10.0% final dividend on September 21, 2012.

Key Metrics:
PE Ratio of Avon Lifesciences is -2.86
Prices/Sales Ratio of Avon Lifesciences is 0.19
Price/Book Ratio of Avon Lifesciences is 0.27

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. The PE ratio and PB Ratio of the company are among its competitors stand at -2.86 and 0.27 respectively.

Leadership of Avon Lifesciences :
Ajit Kamath is Chairman & Non-Exe.Director
Rajendra Kaimal is Non Executive Director
Sunil Pitroda is Independent Director
Abhishek Buddhadev is Independent Director
Urja Shah is Independent Director
Neelam Kumar Murdia is Chief Financial Officer
Jignesh Patel is Co. Secretary & Compl. Officer

Industry

Pharma - Indian

Key Indices Listed On

-

Address

Plot No. 121A/1,Western Hills,Addagutta Society, Opp. JNTU,Hyderabad, Telangana - 500072

Contact

info@avonlifesciences.com

http://kobobiotech.com

PE Ratio(x)	-3.06
EPS - TTM(₹)	-2.11
MCap(₹ Cr.)	15.39
MCap Rank	174
PB Ratio(x)	0.28
Div Yield(%)	-
Face Value(₹)	10.00
52W High(₹)	6.46
52W Low(₹)	1.99
MCap/Sales	0.19
Beta(1 Month)	-0.27
BV/Share(₹)	22.28

1 Day	1.89%
1 Month	N.A.
3 Months	162.6%
1 Year	146.56%
3 Years	165.84%
5 Years	12.35%

R1	-	Pivot -	S1	-
R2	-		S2	-
R3	-		S3	-

Avon Lifesciences - Kobo Biotech Share Price

Key Metrics

Avon Lifesciences share price insights

Avon Lifesciences Share Price Returns

Avon Lifesciences Share Recommendations

News & Analysis

Share Analysis

Unlock Stock Score, Analyst' Ratings & Recommendations

Financials

Technicals

Peer Comparison

Shareholding Pattern

Mutual Funds Ownership

Avon Lifesciences Top Searches

Corporate Actions

About Avon Lifesciences

Executive Leadership

Auditors

FAQs about Avon Lifesciences share

Top Gainers

Top Losers

Equity Quick Links

More from Markets

Trending in Markets

Browse Companies

Popular Categories

Hot on Web

In Case you missed it

Top Searched Companies

Latest News